Ligand validation:3UNI

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3UNI_GOL_B_1341	85%	89%	0.096	0.961	0.33	0.31	-	-	0	0	100%	1
3UNI_GOL_A_1341	73%	84%	0.133	0.959	0.4	0.36	-	-	0	0	100%	1
3UNI_GOL_B_1343	69%	87%	0.131	0.944	0.38	0.31	-	-	0	0	100%	1
3UNI_GOL_B_1340	67%	82%	0.122	0.931	0.45	0.35	-	-	0	0	100%	1
3UNI_GOL_B_1342	65%	88%	0.145	0.947	0.38	0.28	-	-	1	0	100%	1
3UNI_GOL_B_1339	64%	92%	0.134	0.931	0.34	0.2	-	-	0	0	100%	1
3UNI_GOL_A_1342	62%	80%	0.141	0.932	0.45	0.4	-	-	0	0	100%	1
3UNI_GOL_A_1340	61%	95%	0.135	0.925	0.25	0.14	-	-	0	0	100%	1
3UNI_GOL_A_1339	54%	84%	0.147	0.913	0.44	0.33	-	-	0	0	100%	1
3UNC_GOL_B_1339	97%	93%	0.06	0.978	0.3	0.17	-	-	0	0	100%	1
3AMZ_GOL_A_1336	81%	81%	0.106	0.959	0.36	0.46	-	-	0	0	100%	1
3UNA_GOL_A_1341	73%	73%	0.116	0.943	0.62	0.42	-	-	0	0	100%	1
3AM9_GOL_B_1338	40%	37%	0.172	0.884	0.6	1.85	-	1	2	0	100%	1
1V97_GOL_A_5005	36%	0%	0.194	0.888	4.91	6.38	4	3	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1
1M5Q_GOL_W_4006	100%	0%	0.027	0.992	4.89	6.2	5	3	0	0	100%	1
2Y3G_GOL_A_1150	100%	85%	0.029	0.995	0.36	0.39	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.